Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, Jemal A (2017) Colorectal cancer incidence patterns in the United States, 1974–2013. JNCI J Natl Cancer Inst. https://doi.org/10.1093/jnci/djw322

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

Article  CAS  PubMed  Google Scholar 

Mózes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, Fournier C, Staufer K, Stauber RE, Bugianesi E et al (2022) Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut 71:1006–1019. https://doi.org/10.1136/gutjnl-2021-324243

Article  PubMed  Google Scholar 

GBD (2019) Cancer risk factors collaborators the global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the global burden of disease study 2019. Lancet Lond Engl 2022(400):563–591. https://doi.org/10.1016/S0140-6736(22)01438-6

Article  Google Scholar 

Abar L, Vieira AR, Aune D, Sobiecki JG, Vingeliene S, Polemiti E, Stevens C, Greenwood DC, Chan DSM, Schlesinger S et al (2018) Height and body fatness and colorectal cancer risk: an update of the WCRF-AICR systematic review of published prospective studies. Eur J Nutr 57:1701–1720. https://doi.org/10.1007/s00394-017-1557-1

Article  PubMed  Google Scholar 

Crudele L, Piccinin E, Moschetta A (2021) Visceral adiposity and cancer: role in pathogenesis and prognosis. Nutrients 13:2101. https://doi.org/10.3390/nu13062101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu JJ, Druta M, Shibata D, Coppola D, Boler I, Elahi A, Reich RR, Siegel E, Extermann M (2014) Metabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process? J Geriatr Oncol 5:40–48. https://doi.org/10.1016/j.jgo.2013.11.004

Article  PubMed  Google Scholar 

Kay J, Thadhani E, Samson L, Engelward B (2019) Inflammation-induced DNA damage. Mutations Cancer DNA Repair 83:102673. https://doi.org/10.1016/j.dnarep.2019.102673

Article  CAS  PubMed  Google Scholar 

Cariello M, Piccinin E, Zerlotin R, Piglionica M, Peres C, Divella C, Signorile A, Villani G, Ingravallo G, Sabbà C et al (2021) Adhesion of platelets to colon cancer cells is necessary to promote tumor development in xenograft. Genet Inflamm Models Cancers 13:4243. https://doi.org/10.3390/cancers13164243

Article  CAS  Google Scholar 

Lee H, Lee HW, Kim SU, Chang Kim H (2022) Metabolic dysfunction-associated fatty liver disease increases colon cancer risk: a nationwide cohort study. Clin Transl Gastroenterol 13:e00435. https://doi.org/10.14309/ctg.0000000000000435

Article  PubMed  PubMed Central  Google Scholar 

Mantovani A, Dauriz M, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G (2018) Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis. Metabolism 87:1–12. https://doi.org/10.1016/j.metabol.2018.06.004

Article  CAS  PubMed  Google Scholar 

Chen J, Bian D, Zang S, Yang Z, Tian G, Luo Y, Yang J, Xu B, Shi J (2019) The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies. Expert Rev Gastroenterol Hepatol 13:385–395. https://doi.org/10.1080/17474124.2019.1580143

Article  CAS  PubMed  Google Scholar 

Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JPA (2015) Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350:g7607. https://doi.org/10.1136/bmj.g7607

Article  PubMed  Google Scholar 

Allen AM, Hicks SB, Mara KC, Larson JJ, Therneau TM (2019) The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity—a longitudinal cohort study. J Hepatol 71:1229–1236. https://doi.org/10.1016/j.jhep.2019.08.018

Article  PubMed  PubMed Central  Google Scholar 

George ES, Sood S, Kiss N, Daly RM, Nicoll AJ, Roberts SK, Baguley BJ (2022) The evidence surrounding non-alcoholic fatty liver disease in individuals with cancer: a systematic literature review. Curr Oncol 30:48–74. https://doi.org/10.3390/curroncol30010005

Article  PubMed  PubMed Central  Google Scholar 

Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour J-F, Schattenberg JM et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73:202–209. https://doi.org/10.1016/j.jhep.2020.03.039

Article  PubMed  Google Scholar 

Kim MC, Park JG, Jang BI, Lee HJ, Lee WK (2019) Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease. Medicine (Baltimore) 98:e14139. https://doi.org/10.1097/MD.0000000000014139

Article  PubMed  Google Scholar 

Lazarus JV, Castera L, Mark HE, Allen AM, Adams LA, Anstee QM, Arrese M, Alqahtani SA, Bugianesi E, Colombo M et al (2023) Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice. JHEP Rep Innov Hepatol 5:100596. https://doi.org/10.1016/j.jhepr.2022.100596

Article  Google Scholar 

Kim G-A, Lee HC, Choe J, Kim M-J, Lee MJ, Chang H-S, Bae IY, Kim H-K, An J, Shim JH et al (2018) Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol 68:140–146. https://doi.org/10.1016/j.jhep.2017.09.012

Article  Google Scholar 

Mottin CC, Moretto M, Padoin AV, Swarowsky AM, Toneto MG, Glock L, Repetto G (2004) The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 14:635–637. https://doi.org/10.1381/096089204323093408

Article  PubMed  Google Scholar 

Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med J Br Diabet Assoc 23:469–480. https://doi.org/10.1111/j.1464-5491.2006.01858.x

Article  CAS  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP et al (2023) A multi-society delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. https://doi.org/10.1016/j.jhep.2023.06.003

Article  PubMed  Google Scholar 

Bays HE, González-Campoy JM, Henry RR, Bergman DA, Kitabchi AE, Schorr AB, Rodbard HW (2008) Adiposopathy working group is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract 62:1474–1483. https://doi.org/10.1111/j.1742-1241.2008.01848.x

Article  CAS  PubMed  Google Scholar 

Phan AT, Goldrath AW, Glass CK (2017) Metabolic and epigenetic coordination of T cell and macrophage immunity. Immunity 46:714–729. https://doi.org/10.1016/j.immuni.2017.04.016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bovenga F, Sabbà C, Moschetta A (2015) Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer. Cell Metab 21:517–526. https://doi.org/10.1016/j.cmet.2015.03.002

Article  CAS  PubMed  Google Scholar 

Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7:763–777. https://doi.org/10.1038/nrc2222

Article  CAS  PubMed  Google Scholar 

Raccosta L, Fontana R, Corna G, Maggioni D, Moresco M, Russo V (2016) Cholesterol metabolites and tumor microenvironment: the road towards clinical translation. Cancer Immunol Immunother CII 65:111–117. https://doi.org/10.1007/s00262-015-1779-0

Article  CAS  PubMed  Google Scholar 

Herber DL, Cao W, Nefedova Y, Novitskiy SV, Nagaraj S, Tyurin VA, Corzo A, Cho H-I, Celis E, Lennox B et al (2010) Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med 16:880–886. https://doi.org/10.1038/nm.2172

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borgquist S, Butt T, Almgren P, Shiffman D, Stocks T, Orho-Melander M, Manjer J, Melander O (2016) Apolipoproteins, lipids and risk of cancer: apolipoproteins, lipids and risk of cancer. Int J Cancer 138:2648–2656. https://doi.org/10.1002/ijc.30013

Article  CAS  PubMed  Google Scholar 

Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet Lond Engl 371:569–578. https://doi.org/10.1016/S0140-6736(08)60269-X

Article  Google Scholar 

Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638. https://doi.org/10.1056/NEJMoa021423

Article  PubMed  Google Scholar 

Taniguchi K, Karin M (2018) NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 18:309–324. https://doi.org/10.1038/nri.2017.142

Article  CAS  PubMed  Google Scholar 

Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev 25:16–27. https://doi.org/10.1158/1055-9965.EPI-15-0578

Article  PubMed  Google Scholar 

Farinetti A, Zurlo V, Manenti A, Coppi F, Mattioli AV (2017) Mediterranean diet and colorectal cancer: a systematic review. Nutrition 43–44:83–88. https://doi.org/10.1016/j.nut.2017.06.008

Article